CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Astal Laboratories Ltd.

NSE : BSE : 512600 ISIN CODE : INE307N01014Industry : Pharmaceuticals

News

  • Astal Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026 21 Apr 2026 | 13:10 | Dion Global

    As of March 2026 4.70% is owned by Indian Promoters and 95.30% by Public. Top Promoter holding highest number of shares of Astal Laboratories company...more...

  • Astal Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 09 Apr 2026 | 15:19 | Dion Global

    Submission of certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018.more...

  • Astal Laboratories Q3 net profit down 5.22% at Rs 2.36 cr 14 Feb 2026 | 19:20 | Dion Global

    The company reported standalone net profit of Rs 2.36 crore for the quarter ended December 31 2025 as compared to Rs 2.49 crore in the same period la...more...

  • Astal Laboratories - Compliances- Statement Of Deviation & Variation 14 Feb 2026 | 19:10 | Dion Global

    Submission of Statement of Deviation & Variation.more...

  • Astal Laboratories - Results- Financial Results For December 31, 2025. 14 Feb 2026 | 18:06 | Dion Global

    Submission of Unaudited Financial Results for the quarter ended December 31 2025.more...

  • Astal Laboratories - Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, 14Th February, 2026. 14 Feb 2026 | 17:56 | Dion Global

    Submission of Outcome of Board Meeting.more...

  • Astal Laboratories - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Saturday, 14Th February, 2026. 10 Feb 2026 | 19:04 | Dion Global

    Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider an...more...

  • Astal Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended January 14, 2026 23 Jan 2026 | 13:20 | Dion Global

    As of January 2026 4.64% is owned by Indian Promoters and 95.36% by Public. Top Promoter holding highest number of shares of Astal Laborator...more...

  • Astal Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025 22 Jan 2026 | 07:00 | Dion Global

    As of December 2025 18.19% is owned by Indian Promoters and 81.81% by Public. Top Promoter holding highest number of shares of Astal Laboratories com...more...

  • Astal Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 21 Jan 2026 | 15:38 | Dion Global

    Submission of Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018.more...

  • Astal Laboratories - Announcement under Regulation 30 (LODR)-Updates on Acquisition 14 Jan 2026 | 18:26 | Dion Global

    Submission of updates on Acquision.more...

  • Astal Laboratories - Announcement under Regulation 30 (LODR)-Allotment 14 Jan 2026 | 18:23 | Dion Global

    Submission of intimation of allotment of equity shares.more...

  • Astal Laboratories - Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th January, 2026 14 Jan 2026 | 18:18 | Dion Global

    Submission of outcome of board meeting.more...

  • Astal Laboratories - Announcement Under Regulation 30 (LODR)- In-Principle Approval 01 Jan 2026 | 10:13 | Dion Global

    Submission of Intimation of In-Principle Approval for proposed preferential issue of equity shares pursuant to swap shares.more...

  • Astal Laboratories - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 20 29 Dec 2025 | 19:41 | Dion Global

    Intimation of signing of letter of Intent.more...

  • Astal Laboratories - Announcement under Regulation 30 (LODR)-Press Release / Media Release 25 Nov 2025 | 18:26 | Dion Global

    Submission of intimation under Regulation 30 (LODR) Regulations 2015.more...

  • Astal Laboratories - Intimation Of REACH Compliance Certificate. 24 Nov 2025 | 18:59 | Dion Global

    Submission of Intimation of receipt of REACH Compliance Certificate.more...

  • Astal Laboratories Q2 net profit up 29.00% at Rs 2.58 cr 15 Nov 2025 | 11:46 | Dion Global

    The company reported standalone net profit of Rs 2.58 crore for the quarter ended September 30 2025 as compared to Rs 2.00 crore in the same...more...

  • Astal Laboratories - Results- Financial Results For September 30, 2025 14 Nov 2025 | 18:42 | Dion Global

    Submission of financial results for the quarter ended 30th September 2025.more...

  • Astal Laboratories - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, 14Th November, 2025 14 Nov 2025 | 18:18 | Dion Global

    Submission of outcome of the Board Meeting held on 14th November 2025.more...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex76664.21-1.29%
NSE Index23897.95-1.13%
B500DIVL503607.49-1.30%
BSE 1000 10514.13-1.07%
BSE 100LCTMC8965.34-1.07%
BSE Auto 56681.68-0.78%

Commodity

Gold150212-0.03%
Silver2409890.34%
Copper1261.25209.28%
Crude Oil901840.62%
Lead201.549.93%
Mentha Oil1134.36.27%
Nickel1776131.58%

Currency

USD/INR 94.08(0.26 %)
GBP/INR 126.96(0.09 %)
EUR/INR 110.14(-0.10 %)
JPY/INR 0.59(0.08 %)
CAD/INR 68.68(0.04 %)
HKD/INR 12.01(0.25 %)